Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2026-02-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This is a standard regulatory filing in South Korea used when an entity (in this case, Samsung Asset Management) acquires a significant stake (5% or more) in a publicly traded company (Binex). This falls under the 'Major Shareholding Notification' category, which tracks changes in significant ownership levels.
2026-02-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 6.1' report) used to disclose insider shareholdings and changes in ownership by company directors or major shareholders. This falls under the 'Director's Dealing' category as it reports personal share transactions and ownership status by an executive (Hwang Il Gu).
2026-01-08 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the amendment of a previously filed contract disclosure, specifically updating the disclosure deferral period. Since this is a specific regulatory announcement regarding a contract amendment and does not fit into the other specialized categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2025-12-24 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 95% confidence The document is titled '증권 발행결과(자율공시)' which translates to 'Securities Issuance Result (Voluntary Disclosure)'. It details the issuance of a specific type of bond (exchangeable bonds), including issuance amount, dates, and other issuance details. There is no financial statement or comprehensive report content, but rather an announcement of the results of a securities issuance. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes. The document length is short and focused on issuance results, not a full report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2025-11-06 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 95% confidence The document is titled '자기주식처분결과보고서' which translates to 'Report on Disposal of Treasury Shares'. It details the disposal of treasury shares by the company 바이넥스, including the number of shares disposed, dates, and related financial instruments (exchangeable bonds). The document is addressed to the Financial Supervisory Service and includes specifics about the disposal transaction, the shares involved, and the relationship with the counterparty. This type of document is a report on the company's transaction involving its own shares, specifically the disposal of treasury shares. According to the filing definitions, reports about the company buying back or selling its own shares fall under 'Transaction in Own Shares' (POS). The document is not an announcement of a report but the actual report of the transaction. Therefore, the correct classification is POS with high confidence.
2025-11-06 Korean
[기재정정]주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance of exchangeable bonds (교환사채권 발행결정) by the company 바이넥스. It includes extensive information about the purpose of the bond issuance, the use of proceeds for facility investment, capital structure impact, and comparisons of financing options. The document is a regulatory disclosure about a financing decision, specifically about issuing exchangeable bonds backed by treasury shares, including detailed financial and operational rationale. It is not a full financial report like an annual or interim report, nor is it a transcript, audit report, or management discussion. It is a capital/financing update announcing and explaining a financing activity. The document length is substantial and contains detailed financial and strategic information about the capital raising method and its impact. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-11-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.